BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation

Identification of novel targets for triple-negative breast cancer (TNBC) is an urgent task as targeted therapies have increased the lifespans of Oestrogen Receptor (+)/ Progesterone Receptor (+) and HER(2+) cancer patients. Methods: genes involved in protein processing in the endoplasmic reticulum,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Wenyan, Sun, Hefen, Zhao, Yang, Chen, Mengting, Yang, Xueli, Liu, Yang, Jin, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771250/
https://www.ncbi.nlm.nih.gov/pubmed/31588230
http://dx.doi.org/10.7150/thno.35383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771250/
https://www.ncbi.nlm.nih.gov/pubmed/31588230
http://dx.doi.org/10.7150/thno.35383

Ejemplares similares